CHAKA CHIPAWE: Open Payments
NPI 1104378264 · WHITE LAKE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 75 payments from 18 companies in 2025. Trend: 2023 $1,831 · 2024 $1,653 · 2025 $1,548
Food & beverage: $1,548
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 12 | $252 |
| Axsome Therapeutics, Inc. | 6 | $211 |
| Braeburn Inc. | 10 | $204 |
| Vanda Pharmaceuticals Inc. | 12 | $191 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| Novo Nordisk Inc | 6 | $105 |
| ABBVIE INC. | 4 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| PFIZER INC. | 3 | $53 |
Products named: SUBLOCADE, Auvelity, BRIXADI, FANAPT, CAPLYTA, AIRSUPRA, VRAYLAR, Rybelsus.
Industry payments across MI — which companies pay providers there.
